Association of K832R and R952K SNPs of wilson's disease gene with alzheimer's disease

Journal of Alzheimer's Disease

Volumn 29, Issue 4, 2012, Pages 913-919

  Bucossi, Serena ^a,b   Polimanti, Renato ^c   Mariani, Stefania ^a,b   Ventriglia, Mariacarla ^a,b   Bonvicini, Cristian ^b   Migliore, Simone ^b   Manfellotto, Dario ^b   Salustri, Carlo ^d   Vernieri, Fabrizio ^a   Rossini, Paolo M ^e,f   Squitti, Rosanna ^a,b  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^b IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

^d FATEBENEFRATELLI HOSPITAL   (Italy)

^e Fatebenefratelli Hospital Isola Tiberina ^*  (Italy)

^f CATHOLIC UNIVERSITY   (Italy)

Author keywords

Alzheimer's disease; ATP7B; copper; genetic association study; genetics; Wilson's disease

Indexed keywords

APOLIPOPROTEIN E; ARGININE; LYSINE; WILSON DISEASE PROTEIN;

AGED; ALLELE; ALZHEIMER DISEASE; AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HAPLOTYPE MAP; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; NERVE DEGENERATION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84860121391     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2012-111997     Document Type: Article

References (37)

1. Bucossi S, Ventriglia M, Panetta V, Salustri C, Pasqualetti P, Mariani S, Siotto M, Rossini PM, Squitti R (2011) Copper in Alzheimer's disease: A meta-analysis of serum, plasma, and cerebrospinal fluid studies. J Alzheimers Dis 24, 175-185.
2. Koppenol WH (1993) The centennial of the Fenton reaction. Free Radic Biol Med 15, 645-651. (Pubitemid 23353414)
3. Althaus JS, Quinn JF, Kaye JA, Newsome DA, Bisgaier CL, Kanzer SH (2008) Free copper measured directly in serum using a novel device is elevated in Alzheimer's disease. Invest Ophthalmol Vis Sci 49, 5218.
4. Arnal N, Cristalli DO, de Alaniz MJ, Marra CA (2010) Clinical utility of copper, ceruloplasmin, and metallothionein plasma determinations in human neurodegenerative patients and their first-degree relatives. Brain Res 1319, 118-130.
5. Brewer GJ, Kanzer SH, Zimmerman EA, Celmins DF, Heckman SM, Dick R (2010) Copper and ceruloplasmin abnormalities in Alzheimer's disease. Am J Alzheimers Dis Other Demen 25, 490-497.
6. Squitti R, Barbati G, Rossi L, Ventriglia M, Dal Forno G, Cesaretti S, Moffa F, Caridi I, Cassetta E, Pasqualetti P, Calabrese L, Lupoi D, Rossini PM (2006) Excess of non-ceruloplasmin serum copper in AD correlates with MMSE, CSF [beta]-amyloid, and h-tau. Neurology 67, 76-82. (Pubitemid 44305465)
7. Capo CR, Arciello M, Squitti R, Cassetta E, Rossini PM, Calabrese L, Rossi L (2008) Features of ceruloplasmin in the cerebrospinalfluid ofAlzheimer's disease patients. Biometals 21, 367-372.
8. Linder MC, Houle PA, Isaacs E, Moor JR, Scott LE (1979) Copper regulation of ceruloplasmin in copper-deficient rats. Enzyme 24, 23-35. (Pubitemid 9104724)
9. Chutkow JG (1978) Evidence for uptake of nonceruloplas-minic copper in the brain: Effect of ionic copper and amino acids. Proc Soc Exp Biol Med 158, 113-116. (Pubitemid 8375724)
10. Choi BS, Zheng W (2009) Copper transportto the brain by the blood-brain barrier and blood-CSF barrier. Brain Res 1248, 14-21.
11. Hartter DE, Barnea A (1988) Brain tissue accumulates 67cop-per by two ligand-dependent saturable processes. A high affinity, low capacity and a low affinity, high capacity process. J Biol Chem 263, 799-805. (Pubitemid 18044707)
12. Scheinberg IH, Sternlieb I (1984) Wilson's disease. In: Major problems in internal medicine, Smith LHJ, ed. WB Saunders, Philadelphia, PA, 23, pp. 1-171.
13. Hoogenraad T (2001) Wilson's disease, Intermed Medical Publishers Amsterdam/Rotterdam.
14. Walshe JM (2003) Wilson's disease: The importance of measuring serum caeruloplasmin non-immunologically. Ann Clin Biochem 40, 115-121. (Pubitemid 36359861)
15. Danzeisen R, Araya M, Harrison B, Keen C, Solioz M, Thiele D, McArdle HJ (2007) How reliable and robust are current biomarkers for copper status? Br J Nutr 98, 676-683. (Pubitemid 47487934)
16. Loudianos G, Dessi V, Lovicu M, Angius A, Altuntas B, Giacchino R, Marazzi M, Marcellini M, Sartorelli MR, Sturniolo GC, Kocak N, Yuce A, Akar N, Pirastu M, Cao A (1999) Mutation analysisinpatients of Mediterranean descent with Wilson disease: Identification of 19 novel mutations. J Med Genet 36, 833-836. (Pubitemid 29520573)
17. Tanzi RE, Petrukhin K, Chernov I, Pellequer JL, Wasco W, Ross B, Romano DM, Parano E, Pavone L, Brzustowicz LM, et al. (1993) The Wilson disease gene is a copper transporting ATPase with homologytotheMenkes disease gene. Nat Genet 5, 344-350. (Pubitemid 23351304)
18. Bucossi S, Mariani S, Ventriglia M, Polimanti R, Gennarelli M, Bonvicini C, Pasqualetti P, Scrascia F, Migliore S, Vernieri F, Rossini PM, Squitti R (2011) Association between the c. 2495 A>G ATP7B Polymorphism and Sporadic Alzheimer's Disease. Int J Alzheimers Dis 2011, 973692.
19. Gupta A, Maulik M, Nasipuri P, Chattopadhyay I, Das SK, Gangopadhyay PK, Ray K (2007) Molecular diagnosis of Wilson disease using prevalent mutations and informative single-nucleotide polymorphism markers. Clin Chem 53, 1601-1608. (Pubitemid 47340055)
20. Loudianos G, Dessi V, Lovicu M, Angius A, Kanavakis E, Tzetis M, Kattamis C, Manolaki N, Vassiliki G, Karpathios T, Cao A, Pirastu M (1998) Haplotype and mutation analysis in Greek patients with Wilson disease. Eur J Hum Genet 6, 487-491. (Pubitemid 28486343)
21. Loudianos G, Dessi V, Lovicu M, Angius A, Nurchi A, Sturniolo GC, Marcellini M, Zancan L, Bragetti P, Akar N, Yagci R, Vegnente A, Cao A, Pirastu M (1998) Further delineation of the molecular pathology of Wilson disease in the Mediterranean population. Hum Mutat 12, 89-94. (Pubitemid 28294702)
22. Giambattistelli F, Bucossi S, Salustri C, Panetta V, Mariani S, Siotto M, Ventriglia M, Vernieri F, Dell'acqua ML, Cassetta E, Rossini PM, Squitti R (2011) Effects of hemochromatosis and transferrin gene mutations on iron dyshomeostasis, liver dysfunction and on the risk of Alzheimer's disease. Neurobiol Aging, doi: 10. 1016/j. neurobiolaging. 2011. 03. 005.
23. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of department of health and human services task force on Alzheimer's disease. Neurology 34, 939-944. (Pubitemid 14076461)
24. Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, Delacourte A, Galasko D, Gauthier S, Jicha G, Meguro K, O'Brien J, Pasquier F, Robert P, Rossor M, Salloway S, Stern Y, Visser PJ, Scheltens P (2007) Research criteria for the diagnosis of Alzheimer's disease: Revising the NINCDS-ADRDA criteria. Lancet Neurol 6, 734-746. (Pubitemid 47058377)
25. Folstein MF, Folstein SE, McHugh PR (1975) "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12, 189-198.
26. Hixson JE, Vernier DT (1990) Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 31, 545-548. (Pubitemid 20107994)
27. Menashe I, Rosenberg PS, Chen BE (2008) PGA: Power calculator for case-control genetic association analyses. BMC Genet 9, 36.
28. Sole X, Guino E, Valls J, Iniesta R, Moreno V (2006) SNPStats: A web tool for the analysis of association studies. Bioinformatics 22, 1928-1929. (Pubitemid 44283043)
29. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 21, 263-265. (Pubitemid 40202029)
30. Bush AI, Tanzi RE (2008) Therapeutics for Alzheimer's disease based on the metal hypothesis. Neurotherapeutics 5, 421-432. (Pubitemid 351952485)
31. Atwood CS, Moir RD, Huang X, Scarpa RC, Bacarra NM, Romano DM, Hartshorn MA, Tanzi RE, Bush AI (1998) Dramatic aggregation of Alzheimer Afj by Cu (II) is induced by conditions representing physiological acidosis. J Biol Chem 273, 12817-12826. (Pubitemid 28246837)
32. Squitti R, Pasqualetti P, Dal Forno G, Moffa F, Cassetta E, Lupoi D, Vernieri F, Rossi L, Baldassini M, Rossini PM (2005) Excess of serum copper not related to ceruloplasmin in Alzheimer disease. Neurology 64, 1040-1046. (Pubitemid 40388458)
33. Squitti R, Quattrocchi CC, Salustri C, Rossini PM (2008) Ceruloplasmin fragmentation is implicated in 'free' copper deregulation of Alzheimer's disease. Prion 2, 23-27.
34. Luo L, Boerwinkle E, Xiong M (2011) Association studies for next-generation sequencing. Genome Res 21, 1099-1108.
35. Moore JH, Asselbergs FW, Williams SM (2010) Bioinformatics challenges for genome-wide association studies. Bioinformatics 26, 445-455.
36. Moore JH, Williams SM (2009) Epistasis and its implications for personal genetics. Am J Hum Genet 85, 309-320.
37. Brewer GJ (2009) The risks of copper toxicity contributing to cognitive decline in the aging population and to Alzheimer's disease. J Am Coll Nutr 28, 238-242.